Olopatadine hydrochloride ophthalmic solution 0.1%
Sponsors
Alcon Research, Michael Marchand, MD
Conditions
Allergic ConjunctivitisConjunctivitis, AllergicConjunctivitis, Vernal
Phase 3
Phase 4
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
CompletedNCT01109485
Start: 2010-03-31End: 2011-07-31Updated: 2015-05-12
Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis
NCT03186755
Start: 2017-06-11End: 2024-12-31Target: 42Updated: 2022-10-26